Reader response: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We read the article by Yang et al.1 that reported lymphoplasmacyte-rich meningioma mimicking the whole intracranial pachymeningitis. We reported immunoglobulin G4 (IgG4) pachymeningitis in a 43-year-old woman who had a history of lymphoplasmacyte-rich meningioma resection in the right middle cranial fossa at age 17, a right orbital granuloma at age 29, and a pulmonary granuloma at age 31.2 She then developed left hearing loss and a hypertrophic dura in the posterior fossa at age 35. Six years later, her MRI showed a left frontal meningioma. The biopsied sample showed dense lymphoplasmatic infiltration and IgG4 was stained immunohistochemically. Recently, pachymeningitis was found to relate to IgG43; so the previously resected samples (meningioma, orbital granuloma, pulmonary granuloma) were restudied and showed positive IgG4 staining. Therefore, our case was a definite IgG4-related pachymeningitis and neurologic symptoms were again improved by steroid therapy. Idiopathic hypertrophic pachymeningitis and lymphoplasmacyte-rich meningioma can be confused on both imaging and histopathologic grounds.4 Lymphoplasmacyte-rich meningioma was occasionally reported to spontaneously regress. Its origin, whether neoplastic or inflammatory, is controversial. The case reported by Yang et al. might be IgG4-related; therefore, steroid therapy might be worth a try.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.